Descriptor English: | Glial Cell Line-Derived Neurotrophic Factor | ||||||
Descriptor Spanish: |
Factor Neurotrófico Derivado de la Línea Celular Glial
| ||||||
Descriptor Portuguese: | Fator Neurotrófico Derivado de Linhagem de Célula Glial | ||||||
Descriptor French: | Facteur neurotrophique dérivé des cellules gliales | ||||||
Entry term(s): |
Factor, Glial-Derived Neurotrophic GDNF GDNF Growth Factor Glial Cell Derived Neurotrophic Factor Glial Cell Line Derived Neurotrophic Factor Glial Cell-Derived Neurotrophic Factor Glial Cell-Line Derived Neurotrophic Factor Glial Derived Neurotrophic Factor Glial-Derived Neurotrophic Factor Growth Factor, GDNF Neurotrophic Factor, Glial-Derived |
||||||
Tree number(s): |
D12.644.276.860.381.500 D12.776.467.860.381.500 D12.776.631.600.381.500 D23.529.850.381.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D051100 | ||||||
Scope note: | The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE. |
||||||
Annotation: | GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS is also available |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Public MeSH Note: | 2006; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE GROWTH FACTORS 2003-2005, & under NERVE TISSUE PROTEINS 1993-2002 |
||||||
History Note: | 2006(1993) |
||||||
DeCS ID: | 51102 | ||||||
Unique ID: | D051100 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2006/01/01 | ||||||
Date of Entry: | 2005/06/30 | ||||||
Revision Date: | 2020/01/16 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Glial Cell Line-Derived Neurotrophic Factor
- Preferred
Concept UI |
M0233028 |
Scope note | The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE. |
Preferred term | Glial Cell Line-Derived Neurotrophic Factor |
Entry term(s) |
Factor, Glial-Derived Neurotrophic GDNF GDNF Growth Factor Glial Cell Derived Neurotrophic Factor Glial Cell Line Derived Neurotrophic Factor Glial Cell-Derived Neurotrophic Factor Glial Cell-Line Derived Neurotrophic Factor Glial Derived Neurotrophic Factor Glial-Derived Neurotrophic Factor Growth Factor, GDNF Neurotrophic Factor, Glial-Derived |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey